Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has shared an update.
Recordati has provided an update on its share buyback program, initially announced in November 2024 and executed with UBS Europe SE as intermediary. Between January 27 and 31, 2025, the company repurchased 5,041 shares at a weighted average price of €56.0592 per share. As of January 31, 2025, Recordati holds 2,656,699 shares, representing 1.270% of its share capital. This initiative supports the company’s stock options and performance plans, reflecting its strategic financial management and commitment to stakeholders.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical group listed on the Italian Stock Exchange. With roots in a family pharmacy from the 1920s, the company now offers therapeutic solutions in specialty, general medicine, and rare diseases. It operates globally across the EMEA, Americas, and APAC regions, employing over 4,450 people. Recordati is committed to making health a fundamental right and addresses both common and rare health challenges.
YTD Price Performance: 16.80%
Average Trading Volume: 26,179
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €12.2B
See more data about REC stock on TipRanks’ Stock Analysis page.
